The level of plasma homocysteine in patients with non-alcoholic fatty liver disease in combination with type 2 diabetes
Non-alcoholic fatty liver disease (NAFLD) is one of the major causes of chronic diseases of the hepatobiliary zone. Aim. In order to explore new pathogenetic factors of NAFLD examined the level of plasma homocysteine in 110 patients. Methods and results. Patients were divided into two groups -...
Saved in:
| Main Authors: | V. F. Orlovskiy, N. G. Kuchma, A. V. Orlovskiy, N. O. Murenets |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2015-06-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/44489/42746 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Osteoporosis risk prediction in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
by: Yu. A. Titova, et al.
Published: (2020-10-01) -
HOMOCYSTEINЕ AFTER LIVER TRANSPLANTATION IN CHILDREN
by: O. P. Shevchenko, et al.
Published: (2012-12-01) -
Evaluation of comorbidity in patients with alcoholic cirrhosis of the liver associated with non-alcoholic fatty liver disease
by: N. R. Matkovska, et al.
Published: (2020-04-01) -
Non-invasive fibrosis markers and elastography in diagnosis of fibrosis severity in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
by: O. V. Zemlianitsyna, et al.
Published: (2020-02-01) -
The effect of empagliflozin on non-alcoholic fatty liver disease-related parameters in patients with type 2 diabetes mellitus: a randomized controlled trial
by: Fatemeh Shojaei, et al.
Published: (2025-02-01)